Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new page revision label 'Revision: v3.6.6' was added and the previous label 'Revision: v3.6.5' was removed, indicating a minor update to the page's versioning or documentation metadata.SummaryDifference0.0%

- Check21 days agoChange DetectedTwo NIH grant/contract identifiers for 2019 and 2023 were added to the study record, indicating additional funding acknowledgments associated with the trial.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating an incremental update to the page template or content handling. No user-facing content changes are indicated by this update.SummaryDifference0.0%

- Check49 days agoChange DetectedA revision tag was updated from v3.6.3 to v3.6.4, representing an update to the document version used on the study page. This is an administrative versioning change to the study materials.SummaryDifference0.0%

- Check63 days agoChange DetectedResults posted status added and locations expanded to 52 (including Shanghai, China); the page now shows additional DB-period endpoints and data descriptions, reflecting the updated results dataset.SummaryDifference3%

- Check70 days agoChange DetectedPublications section updated to show the final Nat Med citation for the NATRON study with Jun 2026 publication details and full DOI, replacing the previous online-ahead-of-print entry. This clarifies attribution and the publication status of the study in the Publications section.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.